| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | DE202007006374U1 Venentherapeutische Zubereitung und Herstellung dieser Zubereitung Veins Therapeutic preparation and production of this preparation |
| 07/26/2007 | DE10303229B4 Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen Ambroxol and inhibitors of the angiotensin converting enzyme (ACE) pharmaceutical compositions comprising drug preparation and their use for the treatment of neurodegenerative diseases |
| 07/26/2007 | DE102006005827B3 mRNA-Transfektion von adulten Progenitorzellen zur spezifischen Gewebsregeneration mRNA transfection of adult progenitor cells for tissue regeneration specific |
| 07/26/2007 | CA2637459A1 Substituted 4-phenylpiperidines |
| 07/26/2007 | CA2637243A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 07/26/2007 | CA2636634A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810696A1 Gene therapy for treatment of cardiac failure |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1810680A2 Compositions and methods for use in targeting vascular destruction |
| 07/25/2007 | EP1809632A2 Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors |
| 07/25/2007 | EP1809623A1 Process for the preparation of irbesartan hydrochloride |
| 07/25/2007 | EP1809296A2 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 07/25/2007 | EP1809289A1 Use ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1809240A2 Cardiac safe, rapid medication delivery |
| 07/25/2007 | EP1685096B1 Pentafluorosulfanyl benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing the same |
| 07/25/2007 | EP1572628B1 Isophtalic acid derivatives |
| 07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 07/25/2007 | EP1448562B1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1330273B1 Coated implantable medical device |
| 07/25/2007 | EP1286686B1 E-selectin for treating or preventing stroke |
| 07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP1071419B1 Cannabinoids as antioxidants and neuroprotectants |
| 07/25/2007 | EP1056462B1 Use of rhamnolipids as cosmetics |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | CN1328376C Vascular endothelial cell growth factor variants and use thereof |
| 07/25/2007 | CN1328263C Tetrahydroisoquinoline derivative, its preparation method and pharmaceutical composition |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328253C Fumaric acid ibutilide synthesis method |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN1327893C Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 07/25/2007 | CN1327882C Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease |
| 07/25/2007 | CN1327872C 膏药 Plaster |
| 07/25/2007 | CN1327854C Quality control method of agavaceae extract medicinal formulation |
| 07/25/2007 | CN1327853C Method for increasing content of flavone in extracting ginkgo leaves by using affinity ultrafiltration |
| 07/25/2007 | CN1327846C Sofflower injection and its prepn. method |
| 07/25/2007 | CN1327845C Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 07/25/2007 | CN1327833C Hawthorn leave flavone capsules and their preparing method |
| 07/25/2007 | CN1327828C New-type slowly releasing solid Naolilong prepn |
| 07/25/2007 | CN1327826C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 07/25/2007 | CN101006081A Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 07/25/2007 | CN101006059A Substituted tetrahydroisoquinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drugs |
| 07/25/2007 | CN101005842A Modulators of muscarinic receptors |
| 07/25/2007 | CN101003828A Method of producing bioactive peptide for anti high blood pressure by using protease of Switzerland lactobacillus to hydrolyze lactoprotein |
| 07/25/2007 | CN101003827A Method for preparing bioactive peptide of collagen from squid skin, and application |
| 07/25/2007 | CN101003814A Constructing and expressing method for expression plasmid of recombined PEX pronucleus of human |
| 07/25/2007 | CN101003794A Method for constructing recombined adenovirus in PEX outer secretion type of human and application |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 07/25/2007 | CN101003521A A compound valeryl biphenyl of valine |
| 07/25/2007 | CN101003520A A compound butyryl biphenyl of valine |
| 07/25/2007 | CN101003509A New pharmic acceptable salt of pyritinol, and preparation method |
| 07/25/2007 | CN101003500A Sodium sulfonate substitution compound in diphenyl heptane class, and preparation method, and application |
| 07/25/2007 | CN101003481A Preparing compound of phenols difluoro heptane category, and oxidation resistant applcation |
| 07/25/2007 | CN101002930A Medicine composition containing aniracetam and brain protein hydrolyte |
| 07/25/2007 | CN101002928A Oral liquid of traditional Chinese medicine for treating heart trouble |
| 07/25/2007 | CN101002925A Chinese oral medicine for treating vomiting and regurgitation type rheumatic heart disease |
| 07/25/2007 | CN101002920A Chinese oral medicine for treating slow pulse rate type hypotension |
| 07/25/2007 | CN101002917A Chinese medicine for treating thromboangitis obliterans |
| 07/25/2007 | CN101002899A Pure traditional Chinese medicine preparation for treating hemiparalysis |
| 07/25/2007 | CN101002893A Medicine for treating hypertension |
| 07/25/2007 | CN101002892A Oral traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 07/25/2007 | CN101002889A Oral traditional Chinese medicine for treating bitter taste type hypertension |
| 07/25/2007 | CN101002883A Oral traditional Chinese medicine for treating hypertension |
| 07/25/2007 | CN101002882A Oral traditional Chinese medicine for treating mild lumbago type hypertension |
| 07/25/2007 | CN101002880A Compound medicine preparation for treating hypertension, and its application |
| 07/25/2007 | CN101002875A Oral traditional Chinese medicine for treating insufficiency of spleen-qi type rheumatic heart disease |
| 07/25/2007 | CN101002856A Medicine for treating and preventing cardiovascular and cerebrovascular diseases, and its preparing method |
| 07/25/2007 | CN101002843A Medicine composition used for treating cardiovascular and cerebrovascular diseases |
| 07/25/2007 | CN101002828A Method for preparing Danhong injection, and products thereof |
| 07/25/2007 | CN101002825A Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 07/25/2007 | CN101002811A Powder injection containing Americal ginseng total saponin |
| 07/25/2007 | CN101002804A Pure natural preparations used as depressor and hypolipidemic, and preparing method thereof |
| 07/25/2007 | CN101002791A Traditional Chinese medicine composition for treating cerebrovascular disease, and its preparing method |
| 07/25/2007 | CN101002788A Nasal use gel containing active component of methyl astragaloside |
| 07/25/2007 | CN101002787A Inhalant containing active component of methyl astragaloside |
| 07/25/2007 | CN101002770A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 07/25/2007 | CN101002766A Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors |
| 07/25/2007 | CN101002763A Use of isochromanone 4 derivative |
| 07/25/2007 | CN101002625A Beverage for relieving summer heat, and its preparing process |
| 07/25/2007 | CN101002615A Method for producing fat substitute by using pectin as substrate |
| 07/24/2007 | US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/24/2007 | US7247716 Recombinant sequence, its preparation and use |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247645 Dihydropyridine derivatives |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247636 Phenolic guanidine sodium channel blockers |
| 07/24/2007 | US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |